Consensus Core Laboratories Inc.

Equities

CLB

US21867A1051

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
17.07 ^USD	+3.27%		+0.47%	-3.34%

Apr. 24	Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M	MT
Apr. 24	Earnings Flash (CLB) CORE LABORATORIES Reports Q1 EPS $0.19, vs. Street Est of $0.16	MT

Evolution of the average Target Price on Core Laboratories Inc.

Price target over the last 5 years

History of analyst recommendation changes

dad0d0bc240511f.ru2El9BCE39Aq9svkWz2qPnkLm3_S7Gdo0bgZGgWVp8.lrvq-r0RcCltzrR2yR6uncjTQCiPB9P4kA6IJV55Aqb4nOuh4RJxTx-fng~228cc64dd91c568b0127575782026569

Analyst Recommendations on Core Laboratories Inc.

Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	Jan. 29	MT
Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	23-09-18	MT
Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	23-07-31	MT
Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	23-06-30	MT
Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	23-05-01	MT
Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	23-05-01	MT
Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	23-04-28	MT
BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	23-04-18	MT
Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	23-02-07	MT
BofA Securities Upgrades Core Laboratories to Neutral From Underperform	23-01-09	MT
Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	22-10-07	MT
Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	22-09-26	MT
Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	22-08-02	MT
Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	22-08-01	MT
BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	22-07-15	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	22-07-13	MT
Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	22-07-13	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	22-05-02	MT
Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	22-04-18	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating	22-04-11	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $30 from $32, Keeps Equalweight Rating	22-01-18	MT
Morgan Stanley Adjusts Price Target on Core Laboratories to $32 From $34, Maintains Equal-Weight Rating	21-12-07	MT
CORE LABORATORIES N : BofA Securities Downgrades Core Laboratories to Underperform from Neutral, Adjusts Price Target to $32 from $36	21-10-18	MT
CORE LABORATORIES N : Morgan Stanley Adjusts Price Target on Core Laboratories to $34 From $37, Maintains Equal-Weight Rating	21-10-11	MT
CORE LABORATORIES N : Piper Sandler Adjusts Core Laboratories' Price Target to $17.50 From $20, Maintains Neutral Rating	21-08-20	MT